BioSpace News Archive

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at The JMP Securities CNS Forum on Wednesday, August 19, 2020, at 11:00 a.m. Eastern Time. The conference will be held virtually. A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acadia-pharm.com , under the investors section and an archived recording will be available on the website through September 1

GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), the global leader in neonatal and pediatric genetic testing, announced the entrance into an agreement with Pediatrix Medical Group (“Pediatrix”), the nation’s leading provider of maternal-fetal, and pediatric medical and surgical sub

Epirium Bio Announces Commencement of Phase 1 Clinical Trial of EPM-01 in Becker Muscular Dystrophy -- Additionally, European Commission Grants Investigational Medicine EPM-01 Orphan Designation for the Potential Treatment of Becker Muscular Dystrophy --

Landmark Cell Publication Reveals Novel Spatial Biology Discoveries Enabled by the CODEX® Platform New peer-reviewed paper outlines novel organizing principles and spatial interactions between “neighborhoods” of cells in the tumor microenvironment of colorectal cancer. MENLO PARK, Calif.--( BUSINESS WIRE )-- Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the application of the CODEX® platform to a recent Cell publication ti

Provides additional options to help meet increased demand for continuous renal replacement therapy (CRRT) products resulting from COVID-19 pandemic Most recent example of Baxter’s efforts to increase supply of dialysis products used in an acute care environment DEERFIELD, Ill.--( BUSINESS WIRE )-- Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the U.S.

LivaNova to Present Autonomic Regulation Therapy Findings for Heart Failure During European Society of Cardiology Congress 2020

PIC Therapeutics (“PIC”), a biotechnology company focused on transforming the treatment of cancer though the selective modulation of oncogene translation, today announced the appointment of Katherine Bowdish, Ph.D., as its President and Chief Executive Officer. Dr. Bowdish will also join the Board of Directors of PIC. Dr. Bowdish brings more than 20 years of biopharmaceutical business and scientific leadership to PIC

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced it has entered into definitive agreements with institutional and accredited investors for the purchase and sale of shares of its common stock at a purchase price of $2.50 per share in a registered direct offering for gross proceeds of approximately $9 million before deducting placement agent fees and expenses. The closing of the offering is expected to occur on or about Au

Ontera, Inc., the leader in silicon-based nanopore sensing and diagnostics, is taking another step toward realizing its mission of providing better biological information for a healthier planet; this time, by spinning out a new company, Nooma Bio, Inc. (Nooma).

There’s an exciting buildup underway for the 2 nd annual FWD Pharma Conference , slated to be held Aug. 31-Sept. 1, 2020. With a well-curated lineup of marketing and brand practitioners from the leading life sciences organizations, this virtual conference has established itself as the No. 1 digital transformation event for pharma, life sciences and biotech leaders seeking guidance in a complex digital world. Produced by Lincol